ISAPS · Sep 29, 2026
Nearly 17.9 million surgical and 17.3 million non-surgical procedures in 2025. Eyelid surgery leads the surgical list; botulinum toxin still tops the non-surgical list while filler treatments fell sharply. Baseline numbers for any market plan.
Read at source
Money Today · Korea Customs data · Jan 14, 2025
Customs data shows 2024 exports up 17% year on year, with the US market up nearly 78% and Japan emerging. This is the kind of figure AIP tracks monthly across 18 markets.
Read at source
Lao Cai Newspaper · Decree 58/2026/ND-CP · Mar 15, 2026
Decree 58/2026/ND-CP widens the scope: any service that uses drugs, substances or devices to intervene in the body, including injections, is now a conditional business line. Clinics and spas should review their paperwork before inspections.
Read at source
FDA (US) · Jul 22, 2020
The FDA consumer alert states that exosomes used to treat people are biological drugs that need approval, and none is approved today. Useful when a clinic reads a skin-booster label that says "exosome".
Read at source
Money Today · Korea Ministry of Health and Welfare · Apr 3, 2025
Foreign patient numbers rose 93% from 2023, a record since 2009; 56.6% visited dermatology and 11.4% plastic surgery. Clinics serving international patients need multilingual reception flows, which is what Qub-X is built for.
Read at source
CDC (US) · 2024
19 people in 9 states showed botulism-like symptoms after injections in unlicensed settings; 9 were hospitalised. The CDC advises getting injections only at licensed facilities with products of clear origin.
Read at source
No articles for this topic yet.